Source link : https://www.newshealth.biz/health-news/fda-approves-first-biosimilar-to-treat-condition/
Share on PinterestThe FDA has approved biosimilars for macular degeneration treatment. recep-bg/Getty Images The FDA approved two biosimilars for Eylea (aflibercept), a drug used to treat age-related macular degeneration, diabetic retinopathy and other eye conditions. Biosimilars Yesafili and Opuviz work the same way, and have similar safety and efficacy, as Eylea. The biosimilars’ manufacturers have […]
Author : News Health
Publish date : 2024-05-22 22:40:19
Copyright for syndicated content belongs to the linked Source.